Tag: Prescription Drugs
IDSA Issues Rapid Guidelines for Treatment of COVID-19
Expert panel urges that treatments for COVID-19 be given in the context of clinical trials
Novel Agent Promising for the Treatment of Schizophrenia
Reduction in PANSS total score greater for non-D2-receptor-binding drug SEP-363856 versus placebo
Preoperative Metformin Tied to Better Surgical Outcomes
Risks for postop mortality, readmission down among adults with T2DM who received preop metformin
CDC: Overall Prevalence of Self-Reported Hypertension 32.4 Percent
Unadjusted prevalence of self-reported antihypertensive meds use 76.0 percent for those with HTN
Remdesivir May Improve Oxygen-Support Class in Severe COVID-19
Oxygen-support class improved in 68 percent of patients receiving compassionate use of remdesivir
Physicians Report Expanding Use of Off-Label COVID-19 Treatments
Hydroxychloroquine usage increasing rapidly, although plasma from recovered patients perceived as more effective
Chloroquine COVID-19 Trial Stopped After Patient Deaths
Some patients taking a higher dose developed serious heart rhythm disorders, resulting in 11 deaths
NIH Launches Clinical Trial of Hydroxychloroquine for COVID-19
Enrollees include more than 500 adults hospitalized or expected to be hospitalized with COVID-19
CDC Removes Prescribing Guidelines for Antimalarial Drugs
Guidance statement is now shorter than the previous version and no longer provides dosage information
No Treatment Change Needed for Peds IBD During COVID-19 Pandemic
Authors recommend continuing inflammatory bowel disease treatment, including biologics
